Tryptophan 2,3-dioxygenase (1.13.11.11)

Industry

CPC
C12Y113/11011

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y113/00Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)

Current Industry

C12Y113/11011Tryptophan 2,3-dioxygenase (1.13.11.11)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragm...
- Patent number 11,878,053
- Issue date Jan 23, 2024
- IO Biotech ApS
- Mads Hald Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tryptophan oxidase and use thereof
- Patent number 10,961,560
- Issue date Mar 30, 2021
- Ajinomoto Co., Inc.
- Hiroki Yamaguchi
- G01 - MEASURING TESTING
Information Patent Grant
Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragm...
- Patent number 10,736,950
- Issue date Aug 11, 2020
- Herlev Hospital
- Mads Hald Andersen
- G01 - MEASURING TESTING
Information Patent Grant
Nanoplatforms for arginase, indoleamine 2,3-dioxygenase and tryptop...
- Patent number 10,376,599
- Issue date Aug 13, 2019
- Kansas State University Research Foundation
- Stefan H. Bossmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of bone diseases
- Patent number 9,642,897
- Issue date May 9, 2017
- THE UNIVERSITY OF SYDNEY
- Gustavo Duque
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Means and methods for treating and/or preventing natural AHR ligand...
- Patent number 9,593,062
- Issue date Mar 14, 2017
- DEUTSCHLAND KREBSFORSCHUNGSZENTRUM
- Michael Platten
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of cancer treatment using siRNA silencing
- Patent number 8,389,708
- Issue date Mar 5, 2013
- Weiping Min
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tourette syndrom, autism and associated behaviors
- Patent number 5,405,943
- Issue date Apr 11, 1995
- City of Hope
- David E. Comings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for the diagnosis of Tourette syndrome and associated disorders
- Patent number 5,260,196
- Issue date Nov 9, 1993
- City of Hope
- David E. Comings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
MRNAS ENCODING CHIMERIC METABOLIC REPROGRAMMING POLYPEPTIDES AND US...
- Publication number 20240401006
- Publication date Dec 5, 2024
- Moderna TX, Inc.
- Laurie Kenney
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VACCINE COMPOSITIONS COMPRISING TRYPTOPHAN 2,3-DIOXYGENASE OR FRAGM...
- Publication number 20210023191
- Publication date Jan 28, 2021
- Herlev Hospital
- Mads Hald Andersen
- G01 - MEASURING TESTING
Information Patent Application
DRUG TARGETING OF HUMAN INDOLEAMINE 2,3-DIOXYGENASE
- Publication number 20190304569
- Publication date Oct 3, 2019
- Albert Einstein College of Medicine
- Syun-Ru Yeh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tryptophan Oxidase and Use Thereof
- Publication number 20190185904
- Publication date Jun 20, 2019
- AJINOMOTO CO., INC.
- Hiroki Yamaguchi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NANOPLATFORMS FOR ARGINASE, INDOLEAMINE 2,3-DIOXYGENASE AND TRYPTOP...
- Publication number 20180099057
- Publication date Apr 12, 2018
- Kansas State University Research Foundation
- Stefan H. Bossmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VACCINE COMPOSITIONS COMPRISING TRYPTOPHAN 2,3-DIOXYGENASE OR FRAGM...
- Publication number 20170239337
- Publication date Aug 24, 2017
- Herlev Hospital
- Mads Hald Andersen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Kynurenine Pathway Biomarkers Predictive of Anti-Immune Checkpoint...
- Publication number 20160299146
- Publication date Oct 13, 2016
- Dana-Farber Cancer Institute, Inc.
- Levi Garraway
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF BONE DISEASES
- Publication number 20150343037
- Publication date Dec 3, 2015
- NEPEAN BLUE MOUNTAINS LOCAL HEALTH DISTRICT
- Gustavo Duque
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MEANS AND METHODS FOR TREATING AND/OR PREVENTING NATURAL AHR LIGAND...
- Publication number 20140294860
- Publication date Oct 2, 2014
- DEUTSCHES KREBSFORSCHUNGSZENTRUM
- Michael Platten
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD OF CANCER TREATMENT USING SIRNA SILENCING
- Publication number 20090220582
- Publication date Sep 3, 2009
- LONDON HEALTH SCIENCES CENTRE RESEARCH INC.
- Weiping Min
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Tryptophan 2,3-dioxygenase (1.13.11.11)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragm...

Tryptophan oxidase and use thereof

Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragm...

Nanoplatforms for arginase, indoleamine 2,3-dioxygenase and tryptop...

Treatment of bone diseases

Means and methods for treating and/or preventing natural AHR ligand...

Method of cancer treatment using siRNA silencing

Tourette syndrom, autism and associated behaviors

Method for the diagnosis of Tourette syndrome and associated disorders

Patents Applicationslast 30 patents

MRNAS ENCODING CHIMERIC METABOLIC REPROGRAMMING POLYPEPTIDES AND US...

VACCINE COMPOSITIONS COMPRISING TRYPTOPHAN 2,3-DIOXYGENASE OR FRAGM...

DRUG TARGETING OF HUMAN INDOLEAMINE 2,3-DIOXYGENASE

Tryptophan Oxidase and Use Thereof

NANOPLATFORMS FOR ARGINASE, INDOLEAMINE 2,3-DIOXYGENASE AND TRYPTOP...

VACCINE COMPOSITIONS COMPRISING TRYPTOPHAN 2,3-DIOXYGENASE OR FRAGM...

Kynurenine Pathway Biomarkers Predictive of Anti-Immune Checkpoint...

TREATMENT OF BONE DISEASES

MEANS AND METHODS FOR TREATING AND/OR PREVENTING NATURAL AHR LIGAND...

METHOD OF CANCER TREATMENT USING SIRNA SILENCING